| |
|
|
|
Synthetic Biologics Inc  
|
|
0.9116 0.065 (0.08%) |
01-22 16:00 |
|
Open: |
0.8675 |
Pre close: |
0.8463 |
Target:
|
1.37
|
|
High: |
0.95 |
Low: |
0.85 |
Resistance:
|
1.17
1.70
|
|
Volume: |
22,411,533 |
Market Cap: |
49M |
Support:
|
0.32
0.27
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
0.85
 |
MACD |
MACD(12,26):
|
0.12 |
|
MA(20): |
0.66 |
Signal(12,26,9): |
0.11 |
|
MA(100): |
0.45 |
Stochastic Oscillator |
%K(14,3):
|
37.45 |
|
MA(250): |
0.44 |
%D(3): |
36.28 |
|
Average Volume(K) |
3-Month: |
1142732
|
52-Week |
High:
|
1.70 |
|
10-Days: |
2069762 |
Low: |
0.25 |
|
RSI |
RSI(14):
|
65.50 |
Change(%): |
72.0 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.877 |
Return on Equity (ttm) |
-111.5 |
Shares Out. (M) |
19.44 |
|
EPS Est. Current Year |
-0.170 |
Return on Assets (ttm) |
-53.5 |
Shares Float (M) |
19.30 |
|
EPS Est. Next Year |
-0.250 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.13 |
|
EPS Est. Next Quarter |
-0.050 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
8.72 |
|
Forward EPS |
-4.060 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
61 |
|
Book Value (p.s.) |
-0.400 |
EBITDA (p.s.) |
-0.727 |
P/E |
-1.04 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
-2.28 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-13.65 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-8.41 |
P/CF |
-1.30 |
|
|
|
|
|
|
